CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
811-825 of 1225

Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
MinuteCE®Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC

Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
MinuteCE®Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer

Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
MinuteCE®Understanding CNS Lesions in HER2+ Metastatic Breast Cancer

Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
CME/CEVirtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care

Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
CME/CEMaximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices

No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CENo Patient Left Behind! Advancing CKD-Associated Pruritus Care
- advertisement

The Safety of Sodium Oxybate in Treating Narcolepsy
CME/CEThe Safety of Sodium Oxybate in Treating Narcolepsy

A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies

Right Heart Catheterization: Mastery of Precision Techniques
CME/CE Broadcast ReplayRight Heart Catheterization: Mastery of Precision Techniques

Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
CME/CEBreaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
- advertisement

Chairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL
CME/CEChairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL

Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CEPatient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities

















































